Physical activity considerations for the treatment and prevention of obesity.

University of Pittsburgh Department of Health and Physical Activity and Weight Management Research Center, Pittsburgh, PA 15261, USA.
American Journal of Clinical Nutrition (Impact Factor: 6.5). 08/2005; 82(1 Suppl):226S-229S.
Source: PubMed

ABSTRACT Overweight and obesity present significant public health concerns because of the link with numerous chronic health conditions. Excess body weight is a result of an imbalance between energy intake and energy expenditure. Physical activity is the most variable component of energy expenditure and therefore has been the target of behavioral interventions to modify body weight. It appears that physical activity is an important component on long-term weight control, and therefore adequate levels of activity should be prescribed to combat the obesity epidemic. Although there is evidence that 30 min of moderate-intensity physical activity may improve health outcomes, the amount of physical activity that may be necessary to control body weight may be >30 min/d. There is a growing body of scientific literature suggesting that at least 60 min of moderate-intensity physical activity may be necessary to maximize weight loss and prevent significant weight regain. Moreover, adequate levels of physical activity appear to be important for the prevention of weight gain and the development of obesity. Physical activity also appears to have an independent effect on health-related outcomes when compared with body weight, suggesting that adequate levels of activity may counteract the negative influence of body weight on health outcomes. Thus, it is important to target intervention strategies to facilitate the adoption and maintenance of an adequate amount of physical activity to control body weight.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Considerable research has tested physical activity (PA) interventions to prevent and treat overweight and obesity. This comprehensive meta-analysis synthesized the anthropometric effects of supervised exercise interventions and motivational interventions to increase PA. Eligible intervention studies included healthy participants with reported anthropometric outcomes [e.g., body mass index (BMI)]. Extensive searching located 54,642 potentially eligible studies. We included data from 535 supervised exercise and 283 motivational interventions in our syntheses, which used random-effects analyses. Exploratory moderator analyses used meta-analytic analogues of ANOVA and regression. We synthesized data from 20,494 participants in supervised exercise and 94,711 undergoing motivational interventions. The overall mean effect sizes (ES, d) for treatment versus control groups in supervised exercise interventions were 0.20 (treatment vs. control within-group comparison) and 0.22 (between-group comparison). The ES of 0.22 represents a post-intervention BMI of 26.7 kg/m2 for treatment participants relative to 27.7 kg/m2 for controls. The corresponding mean ES for motivational interventions was significantly smaller (d = 0.09 for between group, d = 0.10 for treatment vs. control within-group). Control group within-group comparisons revealed slightly worsening anthropometric outcomes during study participation (d = −0.03 to −0.04). Moderator analyses identified potential variables for future research. These findings document significant improvements in anthropometric effects from both supervised exercise and motivational interventions.
    The Journal of Primary Prevention 08/2014; 35(4). · 1.54 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: There is a wide acknowledgement of obesity as a relevant clinical entity. Such relevance can be inferred by the huge worldwide amount of research and related health promotion and clinical efforts. Though the evidence sustains some cues for the therapeutic success, the overall long-term effectiveness of obesity treatment tends to be not so satisfactory. Scientific literature is not unequivocal in key areas of nutritional intervention, such as the magnitude of caloric restriction, proportion of macronutrients, meal frequency, among others. The same applies to the area of physical activity recommendation for weight control. As a correlate of this scenario of incertitude, there is a proliferation of interventions and there is a clear need to integrate the scientific and clinical evidence. This paper presents a narrative literature review of key issues of clinical practice in obesity, regarding a set of actions that, in the overall, have as main purpose the pro-motion of reduction and/or control of body weight. The role of the health professional is highlighted as a facilitator of acquisition of habits that favor weight control, by integrating the professional's scientific knowledge with the patient's readiness for and capacity to change. INtRODUÇÃO A sobrecarga ponderal e suas comorbilidades são um problema-chave de saúde, com elevados custos biopsicos-socias.
    Acta médica portuguesa 03/2014; 27(1):99-107.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Genetic variants of the melanocortin-4 receptor gene (MC4R), agouti related protein (AGRP) and proopiomelanocortin (POMC) are reported to be associated with obesity. Therefore, the aim of this study is to examine MC4R rs17782313, MC4R rs17700633, AGRP rs3412352 and POMCrs1042571 for any association with obesity in North Indian subjects. The variants were investigated for association in 300 individuals with BMI ≥30 kg/m(2) and 300 healthy non-obese individuals BMI <30 kg/m(2.) The genotyping were analyzed by Taqman probes. The statistical analysis was performed by the SPSS software, ver.19 and p≤0.05 was considered statistically significant. The genotypes of MC4R rs17782313 and POMC rs1042571 were significantly associated with obesity (C), (p=0.02; OR=1.7 and p=0.01; OR=1.6, respectively); however, MC4Rrs17700633 (p=0.001; OR=0.55) was associated with low risk. In addition, AGRPrs3412352 (p=0.93; OR=0.96) showed no association with obesity (BMI ≥30 kg/m(2)) in North Indian subjects. This study provides the report about the significant association of MC4R (rs17782313) and POMC (rs1042571) with morbid obesity (BMI ≥30 kg/m(2)), but MC4R (rs17700633) and AGRP (rs34123523) did not show any association with obesity in the studied North Indian population.
    Oman medical journal. 03/2014; 29(2):114-8.